Chloe Cole Act of 2026
Key claim: The Chloe Cole Act of 2026 (HR7651, 119th Congress) was introduced and referred to the House Committee on the Judiciary.
Abstract
(HR7651 · 119th Congress) Latest action (2026-02-23): Referred to the House Committee on the Judiciary.
Why this matters
The Chloe Cole Act of 2026 is the latest federal legislative vehicle in a heavily contested area where states have taken divergent approaches to regulating puberty blockers, hormones, and surgical interventions for minors. For affected groups — transgender and gender-questioning youth, their parents, and clinicians — a federal restriction would preempt the current state-by-state patchwork and directly implicate parental medical decision-making, professional licensure, and access to care. Its introduction-only status means practical effect is prospective, but the naming after a detransitioner advocate signals the framing likely to shape debate.